These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 29853301)

  • 1. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5
    Eun NL; Son EJ; Gweon HM; Youk JH; Kim JA
    Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scoring system based on BI-RADS lexicon to predict probability of malignancy in suspicious microcalcifications.
    Youk JH; Son EJ; Kim JA; Moon HJ; Kim MJ; Choi CH; Kim EK
    Ann Surg Oncol; 2012 May; 19(5):1491-8. PubMed ID: 22173328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast MRI as a Problem-solving Study in the Evaluation of BI-RADS Categories 3 and 4 Microcalcifications: Is it Worth Performing?
    Shimauchi A; Machida Y; Maeda I; Fukuma E; Hoshi K; Tozaki M
    Acad Radiol; 2018 Mar; 25(3):288-296. PubMed ID: 29191685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction for Breast Cancer in BI-RADS Category 4 Lesion Categorized by Age and Breast Composition of Women in Songklanagarind Hospital.
    Noonpradej S; Wangkulangkul P; Woodtichartpreecha P; Laohawiriyakamol S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):531-536. PubMed ID: 33639670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2017; 12(11):e0188679. PubMed ID: 29190656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness and limitations of the Japan Mammography Guidelines for the categorization of microcalcifications.
    Uematsu T; Kasami M; Yuen S
    Breast Cancer; 2008; 15(4):291-7. PubMed ID: 18288569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of microcalcification descriptors in BI-RADS 4th edition to stratify risk of malignancy.
    Burnside ES; Ochsner JE; Fowler KJ; Fine JP; Salkowski LR; Rubin DL; Sisney GA
    Radiology; 2007 Feb; 242(2):388-95. PubMed ID: 17255409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories.
    Bent CK; Bassett LW; D'Orsi CJ; Sayre JW
    AJR Am J Roentgenol; 2010 May; 194(5):1378-83. PubMed ID: 20410428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of subcategorizing BI-RADS 4 breast lesions associated with microcalcification: a radiology-pathology correlation study.
    Sanders MA; Roland L; Sahoo S
    Breast J; 2010; 16(1):28-31. PubMed ID: 19929890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BI-RADS categorization as a predictor of malignancy.
    Orel SG; Kay N; Reynolds C; Sullivan DC
    Radiology; 1999 Jun; 211(3):845-50. PubMed ID: 10352614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of benignity or malignancy of a lesion using BI-RADS.
    Masroor I
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):686-8. PubMed ID: 16300702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and diagnosis of automated breast ultrasound in patients with BI-RADS category 4 microcalcifications: a retrospective study.
    Yu LF; Dai CC; Zhu LX; Xu XJ; Yan HJ; Jiang CX; Bao LY
    BMC Med Imaging; 2024 May; 24(1):126. PubMed ID: 38807064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
    Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
    Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast microcalcifications: the UK RCR 5-point breast imaging system or BI-RADS; which is the better predictor of malignancy?
    Metaxa L; Healy NA; O'Keeffe SA
    Br J Radiol; 2019 Nov; 92(1103):20190177. PubMed ID: 31365279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scoring System to Stratify Malignancy Risks for Mammographic Microcalcifications Based on Breast Imaging Reporting and Data System 5th Edition Descriptors.
    Youk JH; Gweon HM; Son EJ; Eun NL; Choi EJ; Kim JA
    Korean J Radiol; 2019 Dec; 20(12):1646-1652. PubMed ID: 31854152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the role of dynamic contrast-enhanced MR imaging for patients with BI-RADS 3-4 microcalcifications.
    Jiang Y; Lou J; Wang S; Zhao Y; Wang C; Wang D
    PLoS One; 2014; 9(6):e99669. PubMed ID: 24927476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5.
    Wiratkapun C; Lertsithichai P; Wibulpholprasert B
    J Med Assoc Thai; 2006 Aug; 89(8):1253-9. PubMed ID: 17048437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the diagnostic value of contrast-enhanced breast MR imaging and mammography on patients with BI-RADS 3-5 microcalcifications.
    Li E; Li J; Song Y; Xue M; Zhou C
    PLoS One; 2014; 9(11):e111217. PubMed ID: 25365327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.